PillPropofol
Brands: Diprivan · Propofol
13 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it13 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi USA, LLC | unknown | 15 | SUPPLYING |
| NorthStar Rx LLC | unknown | 4 | SUPPLYING |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Avenacy, LLC | unknown | 3 | SUPPLYING |
| Civica, Inc. | unknown | 3 | SUPPLYING |
| Pfizer Laboratories Div Pfizer Inc | unknown | 3 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 3 | SUPPLYING |
| Amneal Pharmaceuticals Private Limited | unknown | 3 | SUPPLYING |
| Sagent Pharmaceuticals | unknown | 3 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 3 | SUPPLYING |
| Hospira, Inc. | unknown | 3 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | unknown | 3 | SUPPLYING |
| Anthea Pharma Private Limited | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Aug 22, 2022RECALLRecall (Class I): PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further p…
Presence of particulate matter — Recalling firm: Pfizer Inc. — USA Nationwide
- Jul 13, 2022RECALLRecall (Class I): Propofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass fliptop vial (NDC 0409-4699-54) furth…
Presence of particulate matter: particulate identified as a beetle. — Recalling firm: Pfizer Inc. — USA Nationwide
- Apr 13, 2022RECALLRecall (Class II): Diprivan (Propofol) Emulsion, 100 mg/mL, 10mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-10
cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.
- Apr 13, 2022RECALLRecall (Class II): Diprivan (Propofol) Emulsion, 200 mg per 20 mL (10mg/mL), 20 mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-2…
cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.
- Dec 23, 2014RECALLRecall (Class II): Propofol Injectable Emulsion, 1%, 200 mg/20 mL, (10mg/mL), 20 mL, Single patient infusion vial, Contains Benzyl Alcohol…
Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron. — Recalling firm: Hospira Inc. — Nationwide
- Oct 6, 2014RECALLRecall (Class I): Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5 Units per…
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit. — Recalling firm: Hospira Inc. — Distribution limited to one shipment to The Harvard Drug Group, Livonia, MI for the lots of Vancomycin 500 mg, Ketorola…
- Apr 2, 2014RECALLRecall (Class I): Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), For I.V. Administration, Rx Only, 20 mL vial, Contains Benzy…
Presence of Particulate Matter: A glass defect was found on the interior neck of the vial during a retain sample inspection where the glass vial contained visible embedded metallic particulate and free floating metallic particulates were also found in solution. — Recalling firm: Hospira Inc. — Nationwide
- Dec 12, 2013RECALLRecall (Class II): Propofol Injectible Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, packaged in 5 Units x 20…
Presence of Particulate Matter: Glass defect located on the interior neck of the vial identified glass surface abrasions and visible embedded particulate matter which could result in the potential for small glass flakes or embedded metal particulate to become dislodged into the solution. — Recalling firm: Hospira Inc. — Nationwide
- Oct 11, 2013RECALLRecall (Class II): Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL single patient infusion vial packaged in 5 Units x 20 …
Presence of Particulate Matter: Visible particles embedded in the glass identified during a retain sample inspection. — Recalling firm: Hospira Inc. — Nationwide
- Aug 14, 2013RECALLRecall (Class II): Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), packaged in 5 Units x 20 mL Single patient infusion vials pe…
Presence of Particulate Matter: Visible particulate embedded in the glass vial was observed and confirmed in a sample bottle during retain sample inspection. — Recalling firm: Hospira Inc. — Nationwide
- May 25, 2013RECALLRecall (Class II): Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 mL, Single patient infusion vial, RX only, Hospira, Inc., …
Presence of Particulate Matter; single visible particulate was identified during a retain sample inspection identified as stainless steel — Recalling firm: Hospira Inc. — Nationwide
- Apr 8, 2013RECALLRecall (Class II): Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, Rx only, Hospira, Inc., …
Presence of Particulate Matter: A single visible particulate was identified during a retain sample inspection. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico
- Feb 25, 2013RECALLRecall (Class II): Propofol Injectable Emulsion, 1%, packaged in a) 5 x 20 mL Single patient infusion vials per carton, 200 mg/20 mL (10 m…
Presence of Particulate Matter: Visible particulate embedded in vials was observed and confirmed in a sample bottle during retain inspection. — Recalling firm: Hospira Inc. — Nationwide.
- Nov 15, 2012RECALLRecall (Class II): Propofol Injectable Emulsion, 1%, packaged in a) 20 mL Single patient infusion vial, 200 mg/20 mL (10 mg/mL), NDC 0409-…
Presence of Particulate Matter: Visible particulate and particulate embedded in vials were observed during retain inspection. — Recalling firm: Hospira Inc. — Nationwide
- Aug 29, 2012RECALLRecall (Class II): Propofol Injectable Emulsion, 1%, packaged in a) 20 mL Single patient infusion vial, 200 mg/20 mL (10 mg/mL), NDC 0409-…
Presence of Particulate Matter: A single visible particulate was observed and confirmed in sample bottles of the recalled lots during retain inspection. — Recalling firm: Hospira Inc. — Nationwide
- Aug 3, 2012RECALLRecall (Class II): Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial, Rx only, Hospira, Inc. La…
Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection. — Recalling firm: Hospira Inc. — Nationwide
- Apr 11, 2012RECALLRecall (Class II): Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials…
Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel — Recalling firm: Hospira, Inc. — Nationwide.